RELAPSE RATES IN DUODENAL ULCER PATIENTS FORMERLY TREATED WITH BISMUTH SUBCITRATE OR MAINTAINED WITH CIMETIDINE

G. Porro,M. Lazzaroni,M. Petrillo,C. Nicola

DOI: https://doi.org/10.1016/S0140-6736(84)91258-3

IF: 202.731

1984-09-22

The Lancet

Abstract:

What problem does this paper attempt to address?

A Hybrid Plasmonic Waveguide for the Propagation of Surface Plasmon Polariton at 1.55 μm on SOI Substrate

As'ad Amirhosseini,R. Safian

DOI: https://doi.org/10.1109/TNANO.2013.2263987

2013-11-01

IEEE Transactions on Nanotechnology

Abstract:A hybrid plasmonic waveguide (HPW) has been numerically investigated, based on silicon-on-insulator (SOI) structure near the telecom wavelength λ = 1550 nm using the finite-element method. The HPW consists of metal cap placed on SOI rib, which has a trench with a semicircle interface at the bottom of the trench. With the proper choice of waveguide sizes, our proposed HPW can support hybrid long-range surface plasmon which have strong mode confinement Aeff/A0 ≅ 0.0035-0.035 and long propagation length (Leff > 525 μm) simultaneously. In addition, for the proposed HPW, the calculated coupling length for two parallel identical waveguides which is separated by distance d = 250 nm is approximately 1.3 μm, which is very helpful in realizing photonic integration circuits with ultrahigh integration density.
Eigenvector Centrality: Illustrations Supporting the Utility of Extracting More Than One Eigenvector to Obtain Additional Insights into Networks and Interdependent Structures

D. Iacobucci,Rebecca McBride,Deidre Popovich

DOI: https://doi.org/10.21307/JOSS-2018-003

2017-01-01

Journal of Social Structure

Abstract:Abstract Among the many centrality indices used to detect structures of actors’ positions in networks is the use of the first eigenvector of an adjacency matrix that captures the connections among the actors. This research considers the seeming pervasive current practice of using only the first eigenvector. It is shows that, as in other statistical applications of eigenvectors, subsequent vectors can also contain illuminating information. Several small examples, and Freeman’s EIES network, are used to illustrate that while the first eigenvector is certainly informative, the second (and subsequent) eigenvector(s) can also be equally tractable and informative.
Enhancing research integrity and data quality through standardized electronic case report forms

Fabia Diniz-Silva1,Juliana Carvalho Ferreira1,2

DOI: https://doi.org/10.36416/1806-3756/e20240292

2024-09-28

Jornal Brasileiro de Pneumologia

Abstract:The Brazilian Research in Intensive Care Network (BRICNet) designed a multicenter, multinational, cohort study with a 28-day follow-up that will include patients with acute respiratory failure, in transition to spontaneous ventilation in intensive care units in Latin America. 1 1 Diniz-Silva F, Pinheiro BV, Reyes LF, Cavalcanti AB, Figueredo B, Rios F, et al. Adherence to low tidal volume in the transition to spontaneous ventilation in patients with acute respiratory failure in intensive care units in Latin America (SPIRAL): a study protocol. Crit Care Sci. 2024;36:e20240044en. https://doi.org/10.62675/2965-2774.20240044-en https://doi.org/10.62675/2965-2774.20240... Given the multicentric nature of the study and the need to collect data in several countries, which also speak different languages, they were concerned that collecting data in paper forms could lead to errors and opted for using an electronic case report form (CRF) on the Research Electronic Data Capture (REDCap) platform. 2 2 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010 https://doi.org/10.1016/j.jbi.2008.08.01... Data collection is a crucial step in the scientific research process, as the quality of the data obtained directly influences the validity of the results and the reliability of conclusions of the study. Researchers must be meticulous in selecting the appropriate method for data collection to ensure that the collected data effectively address the research question. The use of CRFs ensures standardization in obtaining information and allows for systematic data collection, minimizing variability and bias that may arise from non-standardized collection methods. CRFs should be well-structured, easy to complete, and designed to collect high-quality data. Only the minimum amount of data necessary to address the research question should be collected, avoiding the inclusion of excessive or irrelevant information. A significant advancement in data collection has been the use of electronic forms instead of paper forms, as data collected on paper forms must be transferred to an electronic database to perform data analysis, and data entry errors can occur. 3 3 Pavlovic I, Kern T, Miklavcic D. Comparison of paper-based and electronic data collection process in clinical trials: costs simulation study. Contemp Clin Trials. 2009;30(4):300-316. https://doi.org/10.1016/j.cct.2009.03.008 https://doi.org/10.1016/j.cct.2009.03.00... The use of electronic forms significantly improves data quality control, as it verifies invalid responses and missing data in real time (Chart 1). Electronic CRFs serve as an interface that feeds data into a database and avoid the need to type data directly into a spreadsheet, which is prone to mistakes and should not be an option in research studies. When researchers type data directly into a spreadsheet, they can accidentally type data into the wrong column or line, type over data, and mistakes can go unnoticed. There are several methods for collecting data in electronic forms that directly feed a database, including some that are free of charge and used for informal surveys. However, in order to be reliable for collecting data in research studies, electronic forms need to be built to ensure the integrity of the data, protecting the database from unintended data changes or deletions, and protecting the confidentiality of patient data. The REDCap software, 2 2 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010 https://doi.org/10.1016/j.jbi.2008.08.01... developed by Vanderbilt University, is a web-based platform designed to facilitate the development of electronic data capture forms to be used in research. With REDCap, users can create customized data collection forms and questionnaires according to the specific needs of their studies or download instruments from a shared online library, saving time and resources. To ensure the quality and integrity of the data collected, REDCap has a series of functionalities that -Abstract Truncated-

respiratory system
A qualitative study exploring Emergency Department Staff attitudes to COVID-19 research

Joanna Quinn,Antonia Ho,Andrew Blunsum,David J Lowe

DOI: https://doi.org/10.1101/2024.07.04.24309781

2024-07-07

Abstract:Introduction: Research conducted in the Emergency Department (ED) is essential for improving patient care and advancing evidence-based practice. However, there are several challenges to research engagement in the ED, including lack of time, awareness of research opportunities, and concerns about the impact on clinical duties. This study aimed to explore the attitudes and perceptions of ED staff involved in an enhanced syndromic surveillance of hospitalised severe acute respiratory illness (CHARISMA study) during the COVID-19 pandemic. Methods: This qualitative study utilised semi-structured interviews with a mix of nursing and medical staff with a range of experience levels. Thematic analysis was then undertaken. Results: 9 respondents informed our four key themes: the value of research, the user experience of the study tools, clinician research engagement and improvement recommendations for future iterations of the study. Our findings reveal that ED staff value research and recognise its importance in improving patient care and evidence-based practice. However, they also face significant challenges in participating in research due to time constraints, lack of awareness of research opportunities, and concerns about the impact on clinical duties. Conclusion: To address these challenges, we propose strategies to enhance research engagement in the ED, including providing more support from senior staff, more transparent communication about research studies, training on research methods and tools, and opportunities for feedback and input. Implementing these measures, we can enhance the environment for research in the ED, enabling wider staff contribution.

Emergency Medicine
Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study

Sudhir Venkatesan,Puja R Myles,Gerard McCann,Antonis A Kousoulis,Maimoona Hashmi,Rabah Belatri,Emma Boyle,Alan Barcroft,Tjeerd Pieter van Staa,Jamie J Kirkham,Jonathan S Nguyen Van Tam,Timothy J Williams,Malcolm G Semple

DOI: https://doi.org/10.3310/hta19890

Abstract:Background: During pandemics of novel influenza and outbreaks of emerging infections, surge in health-care demand can exceed capacity to provide normal standards of care. In such exceptional circumstances, triage tools may aid decisions in identifying people who are most likely to benefit from higher levels of care. Rapid research during the early phase of an outbreak should allow refinement and validation of triage tools so that in the event of surge a valid tool is available. The overarching study aim is to conduct a prospective near real-time analysis of structured clinical assessments of influenza-like illness (ILI) using primary care electronic health records (EHRs) during a pandemic. This abstract summarises the preparatory work, infrastructure development, user testing and proof-of-concept study. Objectives: (1) In preparation for conducting rapid research in the early phase of a future outbreak, to develop processes that allow near real-time analysis of general practitioner (GP) assessments of people presenting with ILI, management decisions and patient outcomes. (2) As proof of concept: conduct a pilot study evaluating the performance of the triage tools 'Community Assessment Tools' and 'Pandemic Medical Early Warning Score' to predict hospital admission and death in patients presenting with ILI to GPs during inter-pandemic winter seasons. Design: Prospective near real-time analysis of structured clinical assessments and anonymised linkage to data from EHRs. User experience was evaluated by semistructured interviews with participating GPs. Setting: Thirty GPs in England, Wales and Scotland, participating in the Clinical Practice Research Datalink. Participants: All people presenting with ILI. Interventions: None. Main outcome measures: Study outcome is proof of concept through demonstration of data capture and near real-time analysis. Primary patient outcomes were hospital admission within 24 hours and death (all causes) within 30 days of GP assessment. Secondary patient outcomes included GP decision to prescribe antibiotics and/or influenza-specific antiviral drugs and/or refer to hospital - if admitted, the need for higher levels of care and length of hospital stay. Data sources: Linked anonymised data from a web-based structured clinical assessment and primary care EHRs. Results: In the 24 months to April 2015, data from 704 adult and 159 child consultations by 30 GPs were captured. GPs referred 11 (1.6%) adults and six (3.8%) children to hospital. There were 13 (1.8%) deaths of adults and two (1.3%) of children. There were too few outcome events to draw any conclusions regarding the performance of the triage tools. GP interviews showed that although there were some difficulties with installation, the web-based data collection tool was quick and easy to use. Some GPs felt that a minimal monetary incentive would promote participation. Conclusions: We have developed processes that allow capture and near real-time automated analysis of GP's clinical assessments and management decisions of people presenting with ILI. Future work: We will develop processes to include other EHR systems, attempt linkage to data on influenza surveillance and maintain processes in readiness for a future outbreak. Study registration: This study is registered as ISRCTN87130712 and UK Clinical Research Network 12827. Funding: The National Institute for Health Research Health Technology Assessment programme. MGS is supported by the UK NIHR Health Protection Research Unit in Emerging and Zoonotic Infections.
COVID-19 patient cohort identification during the SARS-CoV-2 outbreak through a tertiary hospital Electronic Health Record alert system (Preprint)

Nicolas Rosillo Ramirez,Aitana Morano-Vázquez,Andrés Mauricio Brandini-Romersi,Álvaro Cadenas-Manceñido,Miguel Pedrera- Jiménez,M. Pilar Arrazola-Martínez,,Pablo Serrano-Balazote,Carolina Varela-Rodríguez

DOI: https://doi.org/10.2196/preprints.35963

2022-01-07

Abstract:BACKGROUND On 11th March 2020, the World Health Organization declared a pandemic caused by the coronavirus with 118.629 identified cases and 4.292 confirmed deaths. Up to date, 252 million cases and 5 million deaths have been identified as caused by COVID-19. An epidemic situation is characterized by an overload of patients suffering a particular clinical condition and needing acute medical attention in a short period. Usually, the pathogen n causing the epidemic is either new or emergent, and the knowledge a priori is limited. Information is crucial for public health authorities to establish policies to prevent transmission. Thus, the cycle of knowledge acquisition must be efficient and as short as possible. An interdisciplinary team adapted the electronic health record alert systems for real-time data tool collection for clinical characterization and epidemiological surveillance. This system has been working from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first outbreak up to date OBJECTIVE To share the experience of handling COVID-19 and non-COVID-19 patients' circuits through an Electronic Health Record (EHR) alert system during the pandemic. This system allowed the creation of a COVID-19 hospitalized patient cohort, with implications in the hospital circuit management, patients risk stratification and secondary use for research projects in a period of high uncertainty. Additionally, its integration as an epidemiological surveillance tool favored the submission of updated information to public health authorities. METHODS Almost 30,000 alerts related to COVID-19 were activated in the EHR. Overall, the most frequent were “COVID-19 ruled out” (N = 12,438) followed by “COVID-19 Confirmed Case” (N = 8,999). Up to 13,106 patients (65.7%) were labeled with just one alert during their in-patient stay, while 6,857 (34.3%) received two or more labels. For the alert sequences, 96% were considered logical sequences, 3,1% as low-quality logic sequences, and less than 1% aberrant sequences. Although some temporal variations, all periods had a high rate of logical sequences achieving more than 95%. Preventive medicine professionals activated most COVID-19 alerts and acted as auditors for data quality. When possible, automatic alerts were in place, which became the most frequent. RESULTS Almost 30,000 alerts related to COVID-19 were activated in the EHR. Overall, the most frequent were “COVID-19 ruled out” (N = 12,438) followed by “COVID-19 Confirmed Case” (N = 8,999). Up to 13,106 patients (65.7%) were labeled with just one alert during their in-patient stay, while 6,857 (34.3%) received two or more labels. For the alert sequences, 96% were considered logical sequences, 3,1% as low-quality logic sequences, and less than 1% aberrant sequences. Although some temporal variations, all periods had a high rate of logical sequences achieving more than 95%. Preventive medicine professionals activated most COVID-19 alerts and acted as auditors for data quality. When possible, automatic alerts were in place, which became the most frequent. CONCLUSIONS The EHR integrated system favored in-hospital management of patients during the COVID-19 pandemic. It was helpful for both the institution and the health system, representing an example of interlevel integration. The performance was adequate and robust, with insights at different levels: infection control, patient safety, research, and pandemic response. Preventive Medicine teams should maximize EHR solutions for epidemiological surveillance. CLINICALTRIAL Not required.
An evaluation of the severe acute respiratory infection (SARI) surveillance system in Ireland

L Marron,R Duffy,J O'Donnell,L Domegan

DOI: https://doi.org/10.1093/eurpub/ckad160.1687

2023-10-01

European Journal of Public Health

Abstract:Abstract Background Expansion of the current single hospital site Severe Acute Respiratory Infection (SARI) surveillance programme in Ireland, to create a sentinel network, will commence in 2023. This evaluation aimed to assess the performance of key surveillance system attributes to improve and guide expansion. Methods A mixed quantitative and qualitative evaluation was conducted from September 2021 to November 2022. SARI surveillance data were analysed to assess completeness, timeliness and positive predictive value (PPV). An online stakeholder questionnaire, semi-structured focus group discussions and key informant interviews evaluated usefulness, simplicity, flexibility and acceptability. Qualitative data were analysed using thematic analysis. Results Among SARI cases (n = 747), completeness of key variables including age, sex and outcome was 100%. Symptom data were completed in > 90%, COVID-19 vaccination status was completed in 89% and completeness of ethnicity data was 0.6%. Median times from hospitalisation to data entry commencement and completion were one day (IQR 1-3) and 48 days (IQR 21-81) respectively. Time to receipt of whole genome sequencing (WGS) results was 40 days (IQR 30-61). PPV was 95% (95% CI 93%-97%). The questionnaire response rate was 21% (75/362) and 96% (72/75) agreed that SARI surveillance is important. Key themes identified in the qualitative study (n = 11) were the complexity and importance of SARI surveillance. Suggested areas for improvement included process automation and additional designated resources to improve timeliness, flexibility and acceptability; particularly during epidemic or pandemic surge periods. Conclusions The SARI surveillance system reports high-quality data. Timeliness of WGS data and recording of vaccination status and equity stratifiers e.g., ethnicity should be improved. Priorities for expansion should be automation and adequate resource allocation to enable reliable SARI surveillance at all times. Key messages • The SARI surveillance system is a resource intensive, complex system that is an important component of national surveillance in Ireland and reports high-quality and timely surveillance data. • The priorities for expansion are process automation where possible and ensuring adequate resources, specifically skilled staff. These evaluation findings should inform SARI expansion in Ireland.

public, environmental & occupational health
[Cerebral infarct and cancer: etiological relationship or incidental finding?].

A. Colon,P. Koehler

Abstract:
Interoperable medical data: The missing link for understanding COVID‐19

Denis C. Bauer,Alejandro Metke‐Jimenez,Sebastian Maurer‐Stroh,Suma Tiruvayipati,Laurence O. W. Wilson,Yatish Jain,Amandine Perrin,Kate Ebrill,David P. Hansen,Seshadri S. Vasan

DOI: https://doi.org/10.1111/tbed.13892

IF: 4.521

2021-01-29

Transboundary and Emerging Diseases

Abstract:<p>Being able to link clinical outcomes to SARS‐CoV‐2 virus strains is a critical component of understanding COVID‐19. Here we discuss how current processes hamper sustainable data collection to enable meaningful analysis and insights. Following the 'Fast Healthcare Interoperable Resource' (FHIR) implementation guide, we introduce an ontology‐based standard questionnaire to overcome these shortcomings and describe patient "journeys" in coordination with the World Health Organization's recommendations. We identify steps in the clinical health data acquisition cycle and workflows that likely have the biggest impact in the data‐driven understanding of this virus. Specifically, we recommend detailed symptoms and medical history using FHIR standards. We have taken the first steps towards this by making patient status mandatory in GISAID immediately resulting in a measurable increase in the fraction of cases with useful patient information. The main remaining limitation is the lack of controlled vocabulary or a medical ontology.</p>

veterinary sciences,infectious diseases
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

ISARIC Clinical Characterization Group,Esteban Garcia-Gallo,Laura Merson,Kalynn Kennon,Sadie Kelly,Barbara Wanjiru Citarella,Daniel Vidali Fryer,Sally Shrapnel,James Lee,Sara Duque,Yuli V Fuentes,Valeria Balan,Sue Smith,Jia Wei,Bronner P Gonçalves,Clark D Russell,Louise Sigfrid,Andrew Dagens,Piero L Olliaro,Joaquin Baruch,Christiana Kartsonaki,Jake Dunning,Amanda Rojek,Aasiyah Rashan,Abi Beane,Srinivas Murthy,Luis Felipe Reyes

DOI: https://doi.org/10.1038/s41597-022-01534-9

2022-07-30

Abstract:The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 dataset is one of the largest international databases of prospectively collected clinical data on people hospitalized with COVID-19. This dataset was compiled during the COVID-19 pandemic by a network of hospitals that collect data using the ISARIC-World Health Organization Clinical Characterization Protocol and data tools. The database includes data from more than 705,000 patients, collected in more than 60 countries and 1,500 centres worldwide. Patient data are available from acute hospital admissions with COVID-19 and outpatient follow-ups. The data include signs and symptoms, pre-existing comorbidities, vital signs, chronic and acute treatments, complications, dates of hospitalization and discharge, mortality, viral strains, vaccination status, and other data. Here, we present the dataset characteristics, explain its architecture and how to gain access, and provide tools to facilitate its use.
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Thomas M Drake,Aya M Riad,Cameron J Fairfield,Conor Egan,Stephen R Knight,Riinu Pius,Hayley E Hardwick,Lisa Norman,Catherine A Shaw,Kenneth A McLean,A A Roger Thompson,Antonia Ho,Olivia V Swann,Michael Sullivan,Felipe Soares,Karl A Holden,Laura Merson,Daniel Plotkin,Louise Sigfrid,Thushan I de Silva,Michelle Girvan,Clare Jackson,Clark D Russell,Jake Dunning,Tom Solomon,Gail Carson,Piero Olliaro,Jonathan S Nguyen-Van-Tam,Lance Turtle,Annemarie B Docherty,Peter Jm Openshaw,J Kenneth Baillie,Ewen M Harrison,Malcolm G Semple,ISARIC4C investigators

DOI: https://doi.org/10.1016/S0140-6736(21)00799-6

2021-07-17

Abstract:Background: COVID-19 is a multisystem disease and patients who survive might have in-hospital complications. These complications are likely to have important short-term and long-term consequences for patients, health-care utilisation, health-care system preparedness, and society amidst the ongoing COVID-19 pandemic. Our aim was to characterise the extent and effect of COVID-19 complications, particularly in those who survive, using the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK. Methods: We did a prospective, multicentre cohort study in 302 UK health-care facilities. Adult patients aged 19 years or older, with confirmed or highly suspected SARS-CoV-2 infection leading to COVID-19 were included in the study. The primary outcome of this study was the incidence of in-hospital complications, defined as organ-specific diagnoses occurring alone or in addition to any hallmarks of COVID-19 illness. We used multilevel logistic regression and survival models to explore associations between these outcomes and in-hospital complications, age, and pre-existing comorbidities. Findings: Between Jan 17 and Aug 4, 2020, 80 388 patients were included in the study. Of the patients admitted to hospital for management of COVID-19, 49·7% (36 367 of 73 197) had at least one complication. The mean age of our cohort was 71·1 years (SD 18·7), with 56·0% (41 025 of 73 197) being male and 81·0% (59 289 of 73 197) having at least one comorbidity. Males and those aged older than 60 years were most likely to have a complication (aged ≥60 years: 54·5% [16 579 of 30 416] in males and 48·2% [11 707 of 24 288] in females; aged <60 years: 48·8% [5179 of 10 609] in males and 36·6% [2814 of 7689] in females). Renal (24·3%, 17 752 of 73 197), complex respiratory (18·4%, 13 486 of 73 197), and systemic (16·3%, 11 895 of 73 197) complications were the most frequent. Cardiovascular (12·3%, 8973 of 73 197), neurological (4·3%, 3115 of 73 197), and gastrointestinal or liver (0·8%, 7901 of 73 197) complications were also reported. Interpretation: Complications and worse functional outcomes in patients admitted to hospital with COVID-19 are high, even in young, previously healthy individuals. Acute complications are associated with reduced ability to self-care at discharge, with neurological complications being associated with the worst functional outcomes. COVID-19 complications are likely to cause a substantial strain on health and social care in the coming years. These data will help in the design and provision of services aimed at the post-hospitalisation care of patients with COVID-19. Funding: National Institute for Health Research and the UK Medical Research Council.
The location of action of chlorpromazine in the central nervous system.

F. Angeleri,M. Carreras

1957-02-01

Abstract:
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024

Xinchun Gu,Conall Watson,Utkarsh Agrawal,Heather Whitaker,William H Elson,Sneha Anand,Ray Borrow,Anna Buckingham,Elizabeth Button,Lottie Curtis,Dominic Dunn,Alex J Elliot,Filipa Ferreira,Rosalind Goudie,Uy Hoang,Katja Hoschler,Gavin Jamie,Debasish Kar,Beatrix Kele,Meredith Leston,Ezra Linley,Jack Macartney,Gemma L Marsden,Cecilia Okusi,Omid Parvizi,Catherine Quinot,Praveen Sebastianpillai,Vanashree Sexton,Gillian Smith,Timea Suli,Nicholas P B Thomas,Catherine Thompson,Daniel Todkill,Rashmi Wimalaratna,Matthew Inada-Kim,Nick Andrews,Victoria Tzortziou-Brown,Rachel Byford,Maria Zambon,Jamie Lopez-Bernal,Simon de Lusignan

DOI: https://doi.org/10.2196/52047

2024-04-03

Abstract:Background: Prepandemic sentinel surveillance focused on improved management of winter pressures, with influenza-like illness (ILI) being the key clinical indicator. The World Health Organization (WHO) global standards for influenza surveillance include monitoring acute respiratory infection (ARI) and ILI. The WHO's mosaic framework recommends that the surveillance strategies of countries include the virological monitoring of respiratory viruses with pandemic potential such as influenza. The Oxford-Royal College of General Practitioner Research and Surveillance Centre (RSC) in collaboration with the UK Health Security Agency (UKHSA) has provided sentinel surveillance since 1967, including virology since 1993. Objective: We aim to describe the RSC's plans for sentinel surveillance in the 2023-2024 season and evaluate these plans against the WHO mosaic framework. Methods: Our approach, which includes patient and public involvement, contributes to surveillance objectives across all 3 domains of the mosaic framework. We will generate an ARI phenotype to enable reporting of this indicator in addition to ILI. These data will support UKHSA's sentinel surveillance, including vaccine effectiveness and burden of disease studies. The panel of virology tests analyzed in UKHSA's reference laboratory will remain unchanged, with additional plans for point-of-care testing, pneumococcus testing, and asymptomatic screening. Our sampling framework for serological surveillance will provide greater representativeness and more samples from younger people. We will create a biomedical resource that enables linkage between clinical data held in the RSC and virology data, including sequencing data, held by the UKHSA. We describe the governance framework for the RSC. Results: We are co-designing our communication about data sharing and sampling, contextualized by the mosaic framework, with national and general practice patient and public involvement groups. We present our ARI digital phenotype and the key data RSC network members are requested to include in computerized medical records. We will share data with the UKHSA to report vaccine effectiveness for COVID-19 and influenza, assess the disease burden of respiratory syncytial virus, and perform syndromic surveillance. Virological surveillance will include COVID-19, influenza, respiratory syncytial virus, and other common respiratory viruses. We plan to pilot point-of-care testing for group A streptococcus, urine tests for pneumococcus, and asymptomatic testing. We will integrate test requests and results with the laboratory-computerized medical record system. A biomedical resource will enable research linking clinical data to virology data. The legal basis for the RSC's pseudonymized data extract is The Health Service (Control of Patient Information) Regulations 2002, and all nonsurveillance uses require research ethics approval. Conclusions: The RSC extended its surveillance activities to meet more but not all of the mosaic framework's objectives. We have introduced an ARI indicator. We seek to expand our surveillance scope and could do more around transmissibility and the benefits and risks of nonvaccine therapies.
Measures and Impact of Caseload Surge During the COVID-19 Pandemic: A Systematic Review

Maniraj Neupane,Nathaniel De Jonge,Sahil Angelo,Sadia Sarzynski,Junfeng Sun,Bram Rochwerg,John Hick,Steven H Mitchell,Sarah Warner,Alex Mancera,Diane Cooper,Sameer S Kadri,Steven H. Mitchell,Sameer S. Kadri

DOI: https://doi.org/10.1097/ccm.0000000000006263

IF: 8.8

2024-03-22

Critical Care Medicine

Abstract:Objectives: COVID-19 pandemic surges strained hospitals globally. We performed a systematic review to examine measures of pandemic caseload surge and its impact on mortality of hospitalized patients. Data Sources: PubMed, Embase, and Web of Science. Study Selection: English-language studies published between December 1, 2019, and November 22, 2023, which reported the association between pandemic “surge”-related measures and mortality in hospitalized patients. Data Extraction: Three authors independently screened studies, extracted data, and assessed individual study risk of bias. We assessed measures of surge qualitatively across included studies. Given multidomain heterogeneity, we semiquantitatively aggregated surge–mortality associations. Data Synthesis: Of 17,831 citations, we included 39 studies, 17 of which specifically described surge effects in ICU settings. The majority of studies were from high-income countries ( n = 35 studies) and included patients with COVID-19 ( n = 31). There were 37 different surge metrics which were mapped into four broad themes, incorporating caseloads either directly as unadjusted counts ( n = 11), nested in occupancy ( n = 14), including additional factors (e.g., resource needs, speed of occupancy; n = 10), or using indirect proxies (e.g., altered staffing ratios, alternative care settings; n = 4). Notwithstanding metric heterogeneity, 32 of 39 studies (82%) reported detrimental adjusted odds/hazard ratio for caseload surge–mortality outcomes, reporting point estimates of up to four-fold increased risk of mortality. This signal persisted among study subgroups categorized by publication year, patient types, clinical settings, and country income status. Conclusions: Pandemic caseload surge was associated with lower survival across most studies regardless of jurisdiction, timing, and population. Markedly variable surge strain measures precluded meta-analysis and findings have uncertain generalizability to lower-middle-income countries (LMICs). These findings underscore the need for establishing a consensus surge metric that is sensitive to capturing harms in everyday fluctuations and future pandemics and is scalable to LMICs.

critical care medicine
Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks

Kajal Patel,Sofia Straudi,Ng Yee Sien,Nora Fayed,John L. Melvin,Manoj Sivan

DOI: https://doi.org/10.3390/ijerph17186476

IF: 4.614

2020-09-05

International Journal of Environmental Research and Public Health

Abstract:(1) Objective: The World Health Organization’s (WHO) International Classification of Functioning, Disability and Health (ICF) classification is a unified framework for the description of health and health-related states. This study aimed to use the ICF framework to classify outcome measures used in follow-up studies of coronavirus outbreaks and make recommendations for future studies. (2) Methods: EMBASE, MEDLINE, CINAHL and PsycINFO were systematically searched for original studies assessing clinical outcomes in adult survivors of severe acute respiratory distress syndrome (SARS), middle east respiratory syndrome (MERS) and coronavirus disease-19 (COVID-19) after hospital discharge. Individual items of the identified outcome measures were linked to ICF second-level and third-level categories using ICF linking rules and categorized according to an ICF component. (3) Results: In total, 33 outcome measures were identified from 36 studies. Commonly used (a) ICF body function measures were Pulmonary Function Tests (PFT), Impact of event scale (IES-R) and Hospital Anxiety and Depression Scale (HADS); (b) ICF activity was 6-Minute Walking Distance (6MWD); (c) ICF participation measures included Short Form-36 (SF-36) and St George’s Respiratory Questionnaire (SGRQ). ICF environmental factors and personal factors were rarely measured. (4) Conclusions: We recommend future COVID-19 follow-up studies to use the ICF framework to select a combination of outcome measures that capture all the components for a better understanding of the impact on survivors and planning interventions to maximize functional return.

public, environmental & occupational health,environmental sciences
Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol

Paulina Stehlik,Caroline Dowsett,Ximena Camacho,Michael O Falster,Renly Lim,Sharifa Nasreen,Nicole L Pratt,Sallie-Anne Pearson,David Henry,Stehlik,P.,Dowsett,C.,Camacho,X.,Falster,M. O.,Lim,R.,Nasreen,S.,Pratt,N. L.,Pearson,S.-A.,Henry,D.

DOI: https://doi.org/10.1136/bmjopen-2023-079071

IF: 3.006

2024-03-20

BMJ Open

Abstract:Background Early evidence on COVID-19 vaccine efficacy came from randomised trials. Many important questions subsequently about vaccine effectiveness (VE) have been addressed using real-world studies (RWS) and have informed most vaccination policies globally. As the questions about VE have evolved during the pandemic so have data, study design, and analytical choices. This scoping review aims to characterise this evolution and provide insights for future pandemic planning—specifically, what kinds of questions are asked at different stages of a pandemic, and what data infrastructure and methods are used? Methods and analysis We will identify relevant studies in the Johns Hopkins Bloomberg School of Public Health VIEW-hub database, which curates both published and preprint VE RWS identified from PubMed, Embase, Scopus, Web of Science, the WHO COVID Database, MMWR, Eurosurveillance, medRxiv, bioRxiv, SSRN, Europe PMC, Research Square, Knowledge Hub, and Google. We will include RWS of COVID-19 VE that reported COVID-19-specific or all-cause mortality (coded as 'death' in the 'effectiveness studies' data set). Information on study characteristics; study context; data sources; design and analytic methods that address confounding will be extracted by single reviewer and checked for accuracy and discussed in a small group setting by methodological and analytic experts. A timeline mapping approach will be used to capture the evolution of this body of literature. By describing the evolution of RWS of VE through the COVID-19 pandemic, we will help identify options for VE studies and inform policy makers on the minimal data and analytic infrastructure needed to support rapid RWS of VE in future pandemics and of healthcare strategies more broadly. Ethics and dissemination As data is in the public domain, ethical approval is not required. Findings of this study will be disseminated through peer-reviewed publications, conference presentations, and working-papers to policy makers. Registration https://doi.org/10.17605/OSF.IO/ZHDKR

medicine, general & internal
Electronic Case Reporting Development, Implementation, and Expansion in the United States

Kimberly Knicely,John W Loonsk,Janet J Hamilton,Annie Fine,Laura A Conn,John W. Loonsk,Janet J. Hamilton,Laura A. Conn

DOI: https://doi.org/10.1177/00333549241227160

2024-02-29

Public Health Reports

Abstract:Public Health Reports, Ahead of Print. Introduction:The COVID-19 pandemic highlighted the need for a nationwide health information technology solution that could improve upon manual case reporting and decrease the clinical and administrative burden on the US health care system. We describe the development, implementation, and nationwide expansion of electronic case reporting (eCR), including its effect on public health surveillance and pandemic readiness.Methods:Multidisciplinary teams developed and implemented a standards-based, shared, scalable, and interoperable eCR infrastructure during 2014-2020. From January 27, 2020, to January 7, 2023, the team conducted a nationwide scale-up effort and determined the number of eCR-capable electronic health record (EHR) products, the number of reportable conditions available within the infrastructure, and technical connections of health care organizations (HCOs) and jurisdictional public health agencies (PHAs) to the eCR infrastructure. The team also conducted data quality studies to determine whether HCOs were discontinuing manual case reporting and early results of eCR timeliness.Results:During the study period, the number of eCR-capable EHR products developed or in development increased 11-fold (from 3 to 33), the number of reportable conditions available increased 28-fold (from 6 to 173), the number of HCOs connected to the eCR infrastructure increased 143-fold (from 153 to 22 000), and the number of jurisdictional PHAs connected to the eCR infrastructure increased 2.75-fold (from 24 to 66). Data quality reviews with PHAs resulted in select HCOs discontinuing manual case reporting and using eCR-exclusive case reporting in 13 PHA jurisdictions. The timeliness of eCR was <1 minute.Practice Implications:The growth of eCR can revolutionize public health case surveillance by producing data that are more timely and complete than manual case reporting while reducing reporting burden.

public, environmental & occupational health
Recombinant maxi-K channels on transistor, a prototype of iono-electronic interfacing

B. Straub,E. Meyer,P. Fromherz

DOI: https://doi.org/10.1038/84369

IF: 46.9

2001-02-01

Nature Biotechnology

Abstract:
Rapid Online Data Collection and Reporting to Local Health Departments during the Pandemic: The COVID-19 Outbreak Public Evaluation (COPE) Initiative SARS-CoV-2 Case Surveys

Lauren A Booker,Mark É Czeisler,Rashon I Lane,Robert C Orellana,Kristen Lundeen,Kathryn Macomber,Jim Collins,Prerna Varma,Shantha M W Rajaratnam,Mark E Howard,Charles A Czeisler,Matthew D Weaver

DOI: https://doi.org/10.1097/PHH.0000000000002017

Abstract:Objectives: To develop and implement a pilot online data collection tool to help local health departments with their COVID-19 pandemic response efforts and inform health department actions. Design: The COVID-19 Outbreak Public Evaluation (COPE) was an online survey and was distributed by participating sites to individuals who recently tested positive for SARS-CoV-2. Surveys recorded participant demographics and assessed recent infection risk behaviors (eg, mask use, air travel), vaccination status, sleep and exercise habits, social behaviors and beliefs, and physical and mental health. Setting: Seven health departments participated in the initiative, which took place during May 1 to September 30, 2022. Identical items were administered to demographically representative samples of adults nationally in the United States within a similar timeframe. Participants: A total of 38 555 participants completed surveys. Responses from participants with recent SARS-CoV-2 infections were compared with respondents from the national surveys who did not have evidence or awareness of prior SARS-CoV-2 infections. Main outcome measure: To implement of a process that allows health departments to receive data from local cases and compare this information to national controls during the COVID-19 pandemic. Results: Fifty-four biweekly reports were provided to public health departments between May and September 2022. Information and comparisons within the reports were updated in response to evolving public health priorities for the pandemic response. The initiative helped to guide public health response efforts during the COVID-19 pandemic. Moreover, the receptiveness by local health departments and participants provides evidence to support this data collection and reporting model as a component of the public health response to future emergencies. Conclusion: This project demonstrates the feasibility of a centralized, rapid, and adaptive data collection system for local health departments and provides evidence to advocate for data collection methods to help guide local health departments to respond in a timely and effective manner to future public health emergencies.
A simple method for forming embryoid body from mouse embryonic stem cells.

H. Kurosawa,Tetsuya Imamura,Mikiko Koike,K. Sasaki,Y. Amano

DOI: https://doi.org/10.1016/S1389-1723(03)90148-4

IF: 3.185

Journal of Bioscience and Bioengineering

Abstract:

RELAPSE RATES IN DUODENAL ULCER PATIENTS FORMERLY TREATED WITH BISMUTH SUBCITRATE OR MAINTAINED WITH CIMETIDINE

A Hybrid Plasmonic Waveguide for the Propagation of Surface Plasmon Polariton at 1.55 μm on SOI Substrate

Eigenvector Centrality: Illustrations Supporting the Utility of Extracting More Than One Eigenvector to Obtain Additional Insights into Networks and Interdependent Structures

Enhancing research integrity and data quality through standardized electronic case report forms

A qualitative study exploring Emergency Department Staff attitudes to COVID-19 research

Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study

COVID-19 patient cohort identification during the SARS-CoV-2 outbreak through a tertiary hospital Electronic Health Record alert system (Preprint)

An evaluation of the severe acute respiratory infection (SARI) surveillance system in Ireland

[Cerebral infarct and cancer: etiological relationship or incidental finding?].

Interoperable medical data: The missing link for understanding COVID‐19

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

The location of action of chlorpromazine in the central nervous system.

Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024

Measures and Impact of Caseload Surge During the COVID-19 Pandemic: A Systematic Review

Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks

Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol

Electronic Case Reporting Development, Implementation, and Expansion in the United States

Recombinant maxi-K channels on transistor, a prototype of iono-electronic interfacing

Rapid Online Data Collection and Reporting to Local Health Departments during the Pandemic: The COVID-19 Outbreak Public Evaluation (COPE) Initiative SARS-CoV-2 Case Surveys

A simple method for forming embryoid body from mouse embryonic stem cells.